IL17A and breast cancer: Studies have also shown increased IL-17-expressing macrophages in active inflammatory bowel disease, high expression of IL-17 in macrophages-mediated inflammatory response in breast cancer as a promoter of invasiveness, and increased production in astrocytes and oligodendrocytes in patients with active multiple sclerosis [27-29].